Expected out of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D beneficiaries as drug plans increasingly tie patient costs to list prices, ...

She learned that she would have to try, and "fail," on two other drugs before Medicare would cover the new one.

Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D ...

In the Proposed Rule, CMS proposes to codify the Part One and Part Two Guidance requirements for CY 2026 and future years of the MPPP, including modification of the list of PDP-required content to ...

The literature contains a wide range of empirical results, including increased charity care and oncology provision from 340B participation, a reduction in Medicare Part B drug costs, and slower ...

Dear Toni: I am turning 65 on April 4, working part time and not eligible for employer benefits, so I need Medicare. A friend gave me confusing advice about enrolling, saying that the seven-month ...

Ozempic/Wegovy is the first drug on HHS's 2025 list of Medicare price negotiations ... these drugs were used by 5.3 million Medicare Part D recipients between November 2023 and October 2024 ...

Medicare Part D provides prescription drug coverage for beneficiaries to support their pharmacological treatment; however, the complex deductible structure within benefit plans creates a major ...

The House Ways and Means Committee in the US voted in favour of a new bill which would end a two-decade-long restriction on the coverage of drugs to ... enrollees in Medicare Part D – which ...